Cat.#: ACPP-1572
| Despition | AIF1 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1441 | Human HOMER1 Protein (AC1441) | 5 µg | inquiry |
| ACPP-1041 | Recombinant Human Wnt3a Protein (AC1041) | 50 µg | inquiry |
| ACPP-1286 | Bestrophin 2 Blocking Peptide (AC1286) | 250 µg | inquiry |
| ACPP-1749 | Human CSNK1D Protein (AC1749) | 5 µg | inquiry |
| ACPP-1838 | Human APO D Protein, GST (AC1838) | 2 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1197 | Dopamine Transporter Blocking Peptide (AC1197) | 250 µg | inquiry |
| ACPP-1663 | Human DUSP6 Protein (AC1663) | 2 µg | inquiry |
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
| ACPP-1544 | Human GAPDH Protein (AC1544) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.